Page last updated: 2024-09-05

sb 203580 and icaritin

sb 203580 has been researched along with icaritin in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(icaritin)
Trials
(icaritin)
Recent Studies (post-2010) (icaritin)
3,48941,1372021178

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)icaritin (IC50)
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)2.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, H; Ou, L; Sun, K; Wang, C; Wang, P; Wu, Z; Xiong, Y; Yang, L; Zhang, R; Zhu, X1

Other Studies

1 other study(ies) available for sb 203580 and icaritin

ArticleYear
Icaritin induces MC3T3-E1 subclone14 cell differentiation through estrogen receptor-mediated ERK1/2 and p38 signaling activation.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 94

    Topics: Animals; Cell Differentiation; Cell Line; Cell Survival; Clone Cells; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Imidazoles; MAP Kinase Signaling System; Mice; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, Estrogen

2017